Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC

Pharmacological inhibition of the Nod-like receptor family protein 3 (NLRP3) inflammasome contributes to the treatment of numerous inflammation-related diseases, making it a desirable drug target. Spirodalesol, derived from the ascomycete fungus Daldinia eschscholzii, has been reported to inhibit NL...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wen, Yang, Jiashu, Fang, Shihao, Jiao, Chenyang, Gao, Jianhua, Zhang, Aihua, Wu, Tiancong, Tan, Renxiang, Xu, Qiang, Guo, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730227/
https://www.ncbi.nlm.nih.gov/pubmed/36379253
http://dx.doi.org/10.1016/j.jbc.2022.102696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730227/
https://www.ncbi.nlm.nih.gov/pubmed/36379253
http://dx.doi.org/10.1016/j.jbc.2022.102696

Ejemplares similares